Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Filings indexed 975 across all filing types
Latest filing 2012-03-12 Declaration of Voting R…
Country FR France
Listing PA FR000

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : Declaration of the number of shares and voting rights as of February 2012, 29
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references Article 223-16 of the General regulations of the French Financial Market Authority (AMF). It provides a table detailing the total number of shares and the corresponding total and net voting rights as of a specific date (February 29, 2012). This content directly relates to the official declaration of voting rights and share capital structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2012-03-12 English
Virbac : Annulation de titres acquis dans le cadre d'un programme de rachat
Share Issue/Capital Change Classification · 99% confidence The document text is very short (633 characters) and announces the cancellation (annulation) of shares previously acquired under a share repurchase program ('programme de rachat'). This action directly relates to the company buying back and subsequently canceling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. It is not an announcement of a report (RPA/RNS), nor is it a general capital change (SHA), but a specific transaction related to treasury stock management.
2012-02-17 French
Virbac : Cancellation of stock acquired through a buy back program
Transaction in Own Shares Classification · 99% confidence The document explicitly announces the 'CANCELLATION OF STOCK ACQUIRED THROUGH A BUY BACK PROGRAM'. It details the number of shares acquired (256,352 shares, representing 2.94% of capital) and confirms that these shares 'have been cancelled effective Friday 17th, February 2012'. This action directly relates to the company managing its own outstanding shares through a repurchase/cancellation mechanism. This aligns perfectly with the definition for Transaction in Own Shares (POS): 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it involves cancellation, the root activity is the management of treasury stock resulting from a buyback program.
2012-02-17 English
Virbac : Déclaration d'actions et de droits de vote au 31 Janvier 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly references the total number of shares and the total gross and net voting rights as of a specific date (January 31, 2012), citing a regulatory article (article 223-16 du Règlement Général de l'Autorité des Marchés Financiers). This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related voting rights disclosures.
2012-02-13 French
Virbac : Declaration of the number of shares and voting rights as of January 2012, 31
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is explicitly titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and provides a table detailing the 'Total number of shares representing the share capital' and the 'Total number of voting rights' as of a specific date (January 31, 2011). This content directly relates to the official declaration of voting rights and share capital structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2012-02-13 English
VIRBAC : SALES GROW 8.7% IN 2011
Earnings Release Classification · 98% confidence The document is a public release dated January 19, 2012, detailing Virbac's consolidated sales for the fourth quarter and the full year 2011. It provides key financial highlights, including total annual sales (€622.8 M€), growth percentages (+8.7% total growth, +8.6% organic growth), and segment performance (companion animals and food producing animals). This structure—a brief announcement focusing on key financial metrics for a reporting period—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor a transcript (CT). The mention of the share buy-back program is secondary to the primary focus on sales results. FY 2011
2012-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.